These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9630322)

  • 1. Bone marrow transplantation and gene therapy for lysosomal storage diseases.
    Hoogerbrugge PM; Valerio D
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S34-6. PubMed ID: 9630322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis.
    Grabowski GA
    Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particularities of lysosomal storage diseases gene therapy.
    Poenaru L
    Gene Ther; 1996 Dec; 3(12):1039-41. PubMed ID: 8986430
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Curr Opin Mol Ther; 2001 Aug; 3(4):399-406. PubMed ID: 11525564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches.
    Haskins M
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S25-7. PubMed ID: 8971403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mini review: animal model of human lysosomal storage disease].
    Sakiyama T
    Nihon Rinsho; 1995 Dec; 53(12):3105-11. PubMed ID: 8577067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.
    Hoogerbrugge PM; Brouwer OF; Bordigoni P; Ringden O; Kapaun P; Ortega JJ; O'Meara A; Cornu G; Souillet G; Frappaz D
    Lancet; 1995 Jun; 345(8962):1398-402. PubMed ID: 7760610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow transplantation for lysosomal storage diseases].
    Imaizumi M
    Nihon Rinsho; 1995 Dec; 53(12):3083-8. PubMed ID: 8577063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in lysosomal storage diseases: a prelude to gene-insertion therapy.
    Yeager AM
    Md Med J; 1990 Apr; 39(4):337-41. PubMed ID: 2110281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy for lysosomal disorders].
    Ohashi T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():671-8. PubMed ID: 16416872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care.
    Wilcox WR
    J Pediatr; 2004 May; 144(5 Suppl):S3-14. PubMed ID: 15126978
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation.
    Lessard MD; Alley TL; Proctor JL; Levy B; Galvin N; Vogler CA; Soper BW
    Clin Immunol; 2006 May; 119(2):166-79. PubMed ID: 16487752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell bone marrow transplantation in patients with metabolic storage diseases.
    Krivit W
    Adv Pediatr; 2002; 49():359-78. PubMed ID: 12214779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of hematopoietic stem cell transplantation in lysosomal storage disease.
    Malatack JJ; Consolini DM; Bayever E
    Pediatr Neurol; 2003 Nov; 29(5):391-403. PubMed ID: 14684234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation for infantile ceramidase deficiency (Farber disease).
    Yeager AM; Uhas KA; Coles CD; Davis PC; Krause WL; Moser HW
    Bone Marrow Transplant; 2000 Aug; 26(3):357-63. PubMed ID: 10967581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in the diagnosis and treatment of lysosomal and peroxisomal disorders.
    Moser HW
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):355-8. PubMed ID: 1623264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.